- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03518762
Sustained Lung Inflation in Preterm Infants
June 7, 2020 updated by: Douaa El Saied El Sherbiny, Kasr El Aini Hospital
Effect of Application of Sustained Lung Inflation on the Respiratory Outcome of Preterm Infants With Respiratory Distress Syndrome
This is a randomized controlled study to investigate the effect of application of sustained lung inflation (SLI) at birth on the respiratory outcome of preterm infants with respiratory distress syndrome.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Enrolled infants (n=160) were randomized before birth into 2 groups (intervention and control group) in a ratio 1:1.
Randomization was done through an online randomizer (www.graphpad.com),
and sealed envelopes were used to assign the infant to one of the two groups.
Study Type
Interventional
Enrollment (Actual)
160
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Cairo, Egypt
- Kasralainy Cairo University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
No older than 1 minute (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Gestational age ≥ 27 weeks and ≤ 32 weeks
- Appropriate for gestational age
- Weight >800 grams
Exclusion Criteria:
- Major congenital anomalies (congenital heart, cerebral, lung or abdominal malformations)
- Fetal hydrops
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Sustained lung inflation
Participants in this arm (n=80) received:
|
SLI was given using a peak pressure of 20 cm H₂O sustained for 15 seconds,using a T-piece resuscitator, Neopuff device
CPAP through an appropriate mask using a pressure 5 cm H₂O,using a T-piece resuscitator, Neopuff device.
|
Other: Control
Participants in this arm (n=80) received:
|
CPAP through an appropriate mask using a pressure 5 cm H₂O,using a T-piece resuscitator, Neopuff device.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Need for invasive mechanical ventilation or death
Time Frame: From birth up to 72 hours of life
|
Treatment failure; defined as the need for intubation and invasive mechanical ventilation or death
|
From birth up to 72 hours of life
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Duration of invasive mechanical ventilation
Time Frame: From date of birth until the date of discharge home or death from any cause, whichever came first, assessed upto 100 days
|
The duration of intubation and invasive mechanical ventilation (in days)
|
From date of birth until the date of discharge home or death from any cause, whichever came first, assessed upto 100 days
|
Pneumothorax
Time Frame: From date of birth until the date of discharge home or death from any cause, whichever came first, assessed upto 100 days
|
Pneumothorax, documented by radiological findings
|
From date of birth until the date of discharge home or death from any cause, whichever came first, assessed upto 100 days
|
Bronchopulmonary dysplasia
Time Frame: Assessed at 36 weeks postmenstrual age or discharge, whichever came first
|
Bronchopulmonary dysplasia, defined as the need for more than 21% oxygen for at least 28 days
|
Assessed at 36 weeks postmenstrual age or discharge, whichever came first
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 21, 2014
Primary Completion (Actual)
January 18, 2017
Study Completion (Actual)
September 5, 2017
Study Registration Dates
First Submitted
April 12, 2018
First Submitted That Met QC Criteria
May 7, 2018
First Posted (Actual)
May 8, 2018
Study Record Updates
Last Update Posted (Actual)
June 9, 2020
Last Update Submitted That Met QC Criteria
June 7, 2020
Last Verified
June 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 75381
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Preterm Infant
-
Duke UniversityNational Institute of Nursing Research (NINR)CompletedPreterm Infant Development | Preterm Infant Health
-
Christiana Care Health ServicesCompletedInfant | Infant, Premature | Infant, Preterm | Infant, LateUnited States
-
NICHD Neonatal Research NetworkEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedInfant, Newborn | Infant, Moderate PretermUnited States
-
Medical University of GrazCompleted
-
NICHD Neonatal Research NetworkEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedInfant, Newborn | Infant, Moderate PretermUnited States
-
University of OxfordShoklo Malaria Research UnitCompleted
-
yangjieCompletedOutcome, Fatal | Preterm Infant | Morbidity;Infant
-
Medical University of GrazCompletedIntubation; Difficult or Failed | Preterm Infant | Term InfantAustria
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaCompletedPreterm Birth | Cerebral Autoregulation | Premature Infant DiseaseItaly
-
IWK Health CentreRecruitingPreterm InfantCanada
Clinical Trials on Sustained lung inflation (SLI)
-
Mansoura University Children HospitalCompletedRespiratory Distress SyndromeEgypt
-
University of FlorenceUnknownRespiratory Distress SyndromeItaly
-
Ain Shams UniversityCompletedRDS of Prematurity
-
King's College LondonKing's College Hospital NHS TrustCompleted
-
Zekai Tahir Burak Women's Health Research and Education...UnknownRespiratory Distress Syndrome
-
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...WithdrawnLung Diseases | Preterm Birth | Respiratory Distress Syndrome
-
Kanuni Sultan Suleyman Training and Research HospitalCompletedRespiratory Distress Syndrome, Newborn | Respiratory Morbidity | Transient Tachypnea of the NewbornTurkey
-
Seoul National University HospitalCompletedPediatric Subclavian Vein CatheterizationKorea, Republic of
-
University of PennsylvaniaEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedPreterm Birth | Extreme PrematurityUnited States, Korea, Republic of, Germany, Netherlands, Australia, Singapore, Austria, Canada, Italy
-
Ain Shams UniversityCompletedRespiratory Distress Syndrome, NewbornEgypt